Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,376 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of low doses of onabotulinumtoxinA for the treatment of refractory idiopathic overactive bladder: a multicentre, double-blind, randomised, placebo-controlled dose-ranging study.
Denys P, Le Normand L, Ghout I, Costa P, Chartier-Kastler E, Grise P, Hermieu JF, Amarenco G, Karsenty G, Saussine C, Barbot F; VESITOX study group in France. Denys P, et al. Among authors: costa p. Eur Urol. 2012 Mar;61(3):520-9. doi: 10.1016/j.eururo.2011.10.028. Epub 2011 Oct 25. Eur Urol. 2012. PMID: 22036776 Clinical Trial.
[Intra-detrusor injection of botulinum toxin for female refractory idiopathic overactive bladder syndrome].
Deffieux X, Fatton B, Denys P, Chartier-Kastler E, Amarenco G, Haab F, Costa P, Game X, Karsenty G, Saussine C, Ballanger P, Le Normand L, Ruffion A, Hermieu JF, Cosson M. Deffieux X, et al. Among authors: costa p. J Gynecol Obstet Biol Reprod (Paris). 2014 Oct;43(8):572-80. doi: 10.1016/j.jgyn.2014.06.011. Epub 2014 Jul 30. J Gynecol Obstet Biol Reprod (Paris). 2014. PMID: 25087018 French.
Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management: Translation of French recommendations.
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler É, Cosson M, Costa P, Fatton B, Saussine C, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Deffieux X. Hermieu JF, et al. Among authors: costa p. Prog Urol. 2014 Sep;24(11):e1-7. doi: 10.1016/j.purol.2014.06.005. Epub 2014 Jul 9. Prog Urol. 2014. PMID: 25214455 Free article.
[Idiopathic overactive bladder and BOTOX(®): Literature review].
Gamé X, Karsenty G, Ruffion A, Amarenco G, Ballanger P, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Haab F, Hermieu JF, Le Normand L, Saussine C, Denys P. Gamé X, et al. Among authors: costa p. Prog Urol. 2015 Jun;25(8):461-73. doi: 10.1016/j.purol.2015.01.006. Epub 2015 Feb 3. Prog Urol. 2015. PMID: 25662706 Review. French.
[Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management].
Hermieu JF, Ballanger P, Amarenco G, Chartier-Kastler E, Cosson M, Costa P, Fatton B, Deffieux X, Denys P, Gamé X, Haab F, Karsenty G, Le Normand L, Ruffion A, Saussine C. Hermieu JF, et al. Among authors: costa p. Prog Urol. 2013 Dec;23(17):1457-63. doi: 10.1016/j.purol.2013.10.006. Epub 2013 Nov 7. Prog Urol. 2013. PMID: 24286546 Free article. French.
3,376 results